Ask AI

Text Module

Share

Program Content

Activities

  • Menin Inhibitors in AML
    A New Revolution in AML Treatment: Can Menin Inhibitors Follow the Path of FLT3 and IDH Inhibitors? 
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 09, 2025

    Expires: March 08, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from Johnson & Johnson, Kura Oncology, Inc. and Syndax Pharmaceuticals, Inc. 

Johnson & Johnson

Kura Oncology, Inc.

Syndax Pharmaceuticals, Inc.